News

You may know about tirzepatide, also known as Mounjaro or Zepbound, due to its popularity for those looking to lose weight or treat diabetes. Now, researchers have gotten it approved to treat sleep ...
Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.
A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen ... been found to be safe and ...
The risk of both all-cause deaths and those caused by cardiovascular conditions in OSA patients is significantly reduced with the use of CPAP therapy.
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
Due to current legislation regarding weight loss drugs, Medicare Part D or Part C plans with drug coverage may only cover Zepbound for treating obstructive sleep apnea (OSA). However, the Centers ...
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed ...
Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...